Added to YB: 2025-10-13
Pitch date: 2025-10-09
GXI.DE [neutral]
Gerresheimer AG
-8.37%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
Market Cap
EUR 856.6M
Pitch Price
EUR 30.60
Price Target
N/A
Dividend
0.16%
EV/EBITDA
7.56
P/E
36.68
EV/Sales
1.35
Sector
Life Sciences Tools and Services
Category
turnaround
Gerresheimer (GXI Germany): Overpromising and underdelivering (yet again)
GXI.DE (quick overview): Pharma packaging co with strong assets (injectable solutions, healthcare exposure) but Q3 missed across sales/earnings, guided FY down again. Regulatory investigation adds uncertainty. Recurring overpromise/underdeliver pattern eroded trust despite low valuation. Structural growth intact but execution risk high.
Read full article (1 min)